GALECTIN THERAPEUTICS INC. Interest Expense
GALECTIN THERAPEUTICS INC. (GALT) reported Interest Expense of $1.05 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-15
- GALECTIN THERAPEUTICS INC. interest expense for the quarter ending 2024-03-31 was $1.05M, a 128.70% increase year-over-year.
- GALECTIN THERAPEUTICS INC. interest expense for the quarter ending 2023-12-31 was $847.00K, a 175.00% increase year-over-year.
- GALECTIN THERAPEUTICS INC. interest expense for the quarter ending 2023-09-30 was $835.00K, a 210.41% increase year-over-year.
- GALECTIN THERAPEUTICS INC. interest expense for the quarter ending 2023-06-30 was $650.00K, a 183.84% increase year-over-year.
- GALECTIN THERAPEUTICS INC. interest expense for fiscal 2023 was $2.79M, a 170.28% increase from fiscal 2022.
- GALECTIN THERAPEUTICS INC. interest expense for fiscal 2022 was $1.03M, a 111.25% increase from fiscal 2021.
- GALECTIN THERAPEUTICS INC. interest expense for fiscal 2021 was $489.00K, a 462.07% increase from fiscal 2020.
- GALECTIN THERAPEUTICS INC. interest expense for fiscal 2020 was $87.00K, a 0.00% change from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 132 month | Interest Expense 135 month | Interest Expense 138 month | Interest Expense 141 month | Interest Expense 144 month | Interest Expense 147 month | Interest Expense 150 month | Interest Expense 153 month | Interest Expense 156 month | Interest Expense 159 month | Interest Expense 162 month | Interest Expense 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $1.05M 10-Q · filed 2024-05-15 | $1.90M derived: sum of 2 quarters · filed 2024-05-15 | $2.73M derived: sum of 3 quarters · filed 2024-05-15 | $3.38M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2023-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.68M derived: sum of 2 quarters · filed 2024-03-29 | $2.33M derived: sum of 3 quarters · filed 2024-03-29 | $2.79M 10-K · filed 2024-03-29 | ||||||||||||
| 2023-09-30 | $835.00K 10-Q · filed 2023-11-13 | $1.49M derived: sum of 2 quarters · filed 2023-11-13 | $1.95M 10-Q · filed 2023-11-13 | $2.25M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2023-06-30 | $650.00K 10-Q · filed 2023-08-14 | $1.11M 10-Q · filed 2023-08-14 | $1.42M derived: sum of 3 quarters · filed 2024-05-15 | $1.69M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2023-03-31 | $460.00K 10-Q · filed 2024-05-15 | $768.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.04M derived: sum of 3 quarters · filed 2024-05-15 | $1.27M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $577.00K derived: sum of 2 quarters · filed 2024-03-29 | $806.00K derived: sum of 3 quarters · filed 2024-03-29 | $1.03M 10-K · filed 2024-03-29 | ||||||||||||
| 2022-09-30 | $269.00K 10-Q · filed 2023-11-13 | $498.00K derived: sum of 2 quarters · filed 2023-11-13 | $725.00K 10-Q · filed 2023-11-13 | $997.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | $229.00K 10-Q · filed 2023-08-14 | $456.00K 10-Q · filed 2023-08-14 | $728.00K derived: sum of 3 quarters · filed 2023-08-14 | $839.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||
| 2022-03-31 | $227.00K 10-Q · filed 2023-05-15 | $499.00K derived: sum of 2 quarters · filed 2023-05-15 | $610.00K derived: sum of 3 quarters · filed 2023-05-15 | $695.00K derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||
| 2021-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $383.00K derived: sum of 2 quarters · filed 2023-03-30 | $468.00K derived: sum of 3 quarters · filed 2023-03-30 | $489.00K 10-K · filed 2023-03-30 | ||||||||||||
| 2021-09-30 | $111.00K 10-Q · filed 2022-11-14 | $196.00K derived: sum of 2 quarters · filed 2022-11-14 | $217.00K 10-Q · filed 2022-11-14 | $240.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $85.00K 10-Q · filed 2022-08-15 | $107.00K 10-Q · filed 2022-08-15 | $129.00K derived: sum of 3 quarters · filed 2022-08-15 | $151.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-16 | $44.00K derived: sum of 2 quarters · filed 2022-05-16 | $66.00K derived: sum of 3 quarters · filed 2022-05-16 | $87.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $44.00K derived: sum of 2 quarters · filed 2022-03-31 | $65.00K derived: sum of 3 quarters · filed 2022-03-31 | $87.00K 10-K · filed 2022-03-31 | ||||||||||||
| 2020-09-30 | $22.00K 10-Q · filed 2021-11-15 | $43.00K derived: sum of 2 quarters · filed 2021-11-15 | $65.00K 10-Q · filed 2021-11-15 | $87.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $21.00K 10-Q · filed 2021-08-16 | $43.00K 10-Q · filed 2021-08-16 | $65.00K derived: sum of 3 quarters · filed 2021-08-16 | $87.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||||
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-17 | $44.00K derived: sum of 2 quarters · filed 2021-05-17 | $66.00K derived: sum of 3 quarters · filed 2021-05-17 | $87.00K derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $44.00K derived: sum of 2 quarters · filed 2021-03-31 | $65.00K derived: sum of 3 quarters · filed 2021-03-31 | $87.00K 10-K · filed 2021-03-31 | ||||||||||||
| 2019-09-30 | $22.00K 10-Q · filed 2020-11-09 | $43.00K derived: sum of 2 quarters · filed 2020-11-09 | $65.00K 10-Q · filed 2020-11-09 | $145.00K derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $21.00K 10-Q · filed 2020-08-10 | $43.00K 10-Q · filed 2020-08-10 | $123.00K derived: sum of 3 quarters · filed 2020-08-10 | $210.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-11 | $102.00K derived: sum of 2 quarters · filed 2020-05-11 | $189.00K derived: sum of 3 quarters · filed 2020-05-11 | $274.00K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $167.00K derived: sum of 2 quarters · filed 2020-03-16 | $252.00K derived: sum of 3 quarters · filed 2020-03-16 | $336.00K 10-K · filed 2020-03-16 | ||||||||||||
| 2018-09-30 | $87.00K 10-Q · filed 2019-11-12 | $172.00K derived: sum of 2 quarters · filed 2019-11-12 | $256.00K 10-Q · filed 2019-11-12 | |||||||||||||
| 2018-06-30 | $85.00K 10-Q · filed 2019-08-09 | $169.00K 10-Q · filed 2019-08-09 | ||||||||||||||
| 2018-03-31 | $84.00K 10-Q · filed 2019-05-10 | |||||||||||||||
| 2017-12-31 | $12.00K 10-K · filed 2019-03-06 | |||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 165 month − 10-K 162 month · filed 2014-05-13 | $0.00 derived: sum of 2 quarters · filed 2014-05-13 | $0.00 derived: sum of 3 quarters · filed 2014-05-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-13 | $4.45M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $0.00 derived: 10-K 162 month − 10-Q 159 month · filed 2014-03-21 | $0.00 derived: sum of 2 quarters · filed 2014-03-21 | $0.00 derived: sum of 3 quarters · filed 2014-03-21 | $0.00 derived: sum of 4 quarters · filed 2014-03-21 | $4.45M 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 159 month − 10-Q 156 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2013-11-12 | $4.45M 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-08-14 | $0.00 derived: sum of 2 quarters · filed 2013-08-14 | $4.45M 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 153 month − 10-K 150 month · filed 2013-05-10 | $4.45M 10-Q · filed 2013-05-10 | ||||||||||||||
| 2012-12-31 | $4.45M 10-K · filed 2013-03-29 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 147 month − 10-Q 144 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $0.00 derived: sum of 3 quarters · filed 2012-11-09 | $0.00 derived: sum of 4 quarters · filed 2012-11-09 | $4.45M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-08-10 | $0.00 derived: sum of 2 quarters · filed 2012-08-10 | $0.00 derived: sum of 3 quarters · filed 2012-08-10 | $0.00 derived: sum of 4 quarters · filed 2012-08-10 | $4.45M 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 141 month − 10-K 138 month · filed 2012-05-11 | $0.00 derived: sum of 2 quarters · filed 2012-05-11 | $0.00 derived: sum of 3 quarters · filed 2012-05-11 | $4.45M 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 138 month − 10-Q 135 month · filed 2012-03-30 | $0.00 derived: sum of 2 quarters · filed 2012-03-30 | $4.45M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 135 month − 10-Q 132 month · filed 2011-11-10 | $4.45M 10-Q · filed 2011-11-10 | ||||||||||||||
| 2011-06-30 | $4.45M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |